Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)

  • S. R. Saifuddin1,
  • W. Devlies2, 3,
  • A. Santaolalla1,
  • F. Cahill1,
  • G. George1,
  • D. Enting3,
  • S. Rudman3,
  • P. Cathcart4,
  • B. Challacombe4,
  • P. Dasgupta4,
  • C. Galustian5,
  • A. Chandra6,
  • S. Chowdhury3,
  • C. Gillett7 and
  • M. Van Hemelrijck1Email author
Contributed equally
BMC Cancer201717:784

https://doi.org/10.1186/s12885-017-3773-8

Received: 13 March 2017

Accepted: 13 November 2017

Published: 22 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Mar 2017 Submitted Original manuscript
7 Jul 2017 Reviewed Reviewer Report - Johannes Huber
17 Jul 2017 Reviewed Reviewer Report - Abdelbaset Buhmeida
24 Jul 2017 Reviewed Reviewer Report - Stefano Carlo Maria Picozzi
1 Aug 2017 Reviewed Reviewer Report - Okyaz Eminaga
4 Sep 2017 Author responded Author comments - Sarah Saifuddin
Resubmission - Version 2
4 Sep 2017 Submitted Manuscript version 2
19 Oct 2017 Author responded Author comments - Sarah Saifuddin
Resubmission - Version 3
19 Oct 2017 Submitted Manuscript version 3
Publishing
13 Nov 2017 Editorially accepted
22 Nov 2017 Article published 10.1186/s12885-017-3773-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
School of Cancer and Pharmaceutical Sciences, Translational Oncology & Urology Research, King’s College London
(2)
Faculty of Medicine, KU Leuven
(3)
Oncology Department, Guy’s and St Thomas’ NHS Foundation Trust
(4)
Urology Centre, Guy’s and St Thomas’ NHS Foundation Trust
(5)
MRC Centre for Transplantation, Faculty of Life Sciences & Medicine, King’s College London
(6)
Pathology Department, Guy’s and St Thomas’ NHS Foundation Trust
(7)
King’s Health Partners Cancer Biobank, Guy’s Hospital

Advertisement